MDT Medtronic plc

  1. Stocks
  2. Healthcare
  3. NYSE: MDT

Price (delayed)

$103.15

Market cap

$138.69B

P/E Ratio

29.56

Dividend/share

$2.47

EPS

$3.49

Enterprise value

$161.41B

Medtronic plc, headquartered in Dublin, Ireland, is among the world's largest medical technology, services and solutions companies - alleviating pain, restoring health and extending life for millions of people around ...

Highlights
The price to earnings (P/E) is 34% lower than the last 4 quarters average of 45.2 and 14% lower than the 5-year quarterly average of 34.6
The net income has grown by 33% YoY and by 21% from the previous quarter
Sector: Healthcare
Industry: Medical Devices
Website: http://www.medtronic.com
Peers: BSX SYK EW JNJ

Key stats

What are the main financial stats of MDT
Market
Shares outstanding
1.34B
Market cap
$138.69B
Enterprise value
$161.41B
Valuations
Price to earnings (P/E)
29.56
Price to book (P/B)
2.67
Price to sales (P/S)
4.36
EV/EBIT
28.6
EV/EBITDA
19.33
EV/Sales
5.08
Earnings
Revenue
$31.8B
EBIT
$5.64B
EBITDA
$8.35B
Free cash flow
$5.77B
Per share
EPS
$3.49
Free cash flow per share
$4.29
Book value per share
$38.63
Revenue per share
$23.64
TBVPS
$25
Balance sheet
Total assets
$91.76B
Total liabilities
$39.6B
Debt
$25.62B
Equity
$51.99B
Working capital
$14.93B
Liquidity
Debt to equity
0.49
Current ratio
2.91
Quick ratio
2.07
Net debt/EBITDA
2.72
Margins
EBITDA margin
26.3%
Gross margin
67.4%
Net margin
14.8%
Operating margin
16.7%
Efficiency
Return on assets
5%
Return on equity
9.1%
Return on invested capital
11.6%
Return on capital employed
6.7%
Return on sales
17.7%
Dividend
Dividend yield
2.39%
DPS
$2.47
Payout ratio
70.8%

MDT stock price

How has the Medtronic stock price performed over time
Intraday
-0.9%
1 week
-2.79%
1 month
-1.23%
1 year
-7.49%
YTD
-0.29%
QTD
-0.29%

Financial performance

How have Medtronic's revenue and profit performed over time
Revenue
$31.8B
Gross profit
$21.43B
Operating income
$5.3B
Net income
$4.7B
Gross margin
67.4%
Net margin
14.8%
The operating income has increased by 49% YoY and by 14% QoQ
The net income has grown by 33% YoY and by 21% from the previous quarter
The operating margin has increased by 30% year-on-year and by 13% since the previous quarter
MDT's net margin is up by 20% since the previous quarter and by 17% year-on-year

Growth

What is Medtronic's growth rate over time

Valuation

What is Medtronic stock price valuation
P/E
29.56
P/B
2.67
P/S
4.36
EV/EBIT
28.6
EV/EBITDA
19.33
EV/Sales
5.08
The price to earnings (P/E) is 34% lower than the last 4 quarters average of 45.2 and 14% lower than the 5-year quarterly average of 34.6
The EPS rose by 33% year-on-year and by 21% since the previous quarter
The stock's price to book (P/B) is 16% less than its last 4 quarters average of 3.2 but 3.5% more than its 5-year quarterly average of 2.6
The company's equity rose by 3.6% YoY
MDT's P/S is 20% lower than its last 4 quarters average of 5.5
Medtronic's revenue has increased by 14% YoY

Efficiency

How efficient is Medtronic business performance
The company's return on invested capital rose by 35% YoY and by 12% QoQ
MDT's return on assets is up by 32% year-on-year and by 22% since the previous quarter
Medtronic's return on equity has increased by 30% YoY and by 20% QoQ
The return on sales rose by 28% year-on-year and by 11% since the previous quarter

Dividends

What is MDT's dividend history
Dividend details
DPS
$2.47
Dividend yield
2.39%
Payout ratio
70.8%
Recent dividends

Financial health

How did Medtronic financials performed over time
The total assets is 132% greater than the total liabilities
The company's current ratio rose by 35% YoY
Medtronic's quick ratio has increased by 27% YoY
MDT's debt is 51% smaller than its equity
Medtronic's debt to equity has decreased by 18% YoY and by 2% from the previous quarter
MDT's debt is down by 15% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.